Scenarios that move LGND

Ligand Pharmaceuticals Incorporated - Common Stock

Scenarios that move LGND: 1 analysis, 1 positive, 0 negative.

  1. · Zymeworks updates 2026 guidance after Theravance acquisition — ▲ · impact +14 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing